Solvay successfully completes the last REACH registration phase

Title_Solstice_DEC17Click to enlarge

Brussels, June 5 , 2018 ---Solvay has completed the third and final phase of registering chemical substances as part of the European Union’s REACH* regulation that aims to improve the protection of human health and the environment.

Solvay registered 403 dossiers, taking the total to 854 dossiers since REACH entered into force in 2007. For 257 of those, Solvay is the lead or only registrant. 

“About one hundred Solvay employees did a professional job for Solvay to be able to successfully complete all registration phases. REACH has significantly contributed to a better communication with customers and suppliers about the properties and risks of products in the supply chain,” said Alain Faessler, Solvay Group General Manager for Industrial.

Following the completion of registration in the EU, Solvay will continue registration for similar REACH regulations in other countries and zones, including Korea (11 dossiers submitted in June 2018) and Turkey (more than 100 dossiers to be submitted by 2023).

Solvay’s ambition is to be a leading contributor to the reshaping of the global chemical industry and help deliver solutions that will meet the planet’s sustainability challenges. 

*REACH stands for the Registration, Evaluation, Authorization and Restriction of Chemicals and represents the major chemical law in Europe.


Solvay is an advanced materials and chemical company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers in diverse global end markets. Its products are used in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction, enhancing efficiency and sustainability. Its lightweighting materials promote cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 24,500 employees in 61 countries. Net sales were € 10.1 billion in 2017, with 90% from activities where Solvay ranks among the world’s top 3 leaders, resulting in an EBITDA margin of 22%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program. (Figures take into account the announced divestment of Polyamides.)